
STAA
STAAR Surgical Company
Company Overview
| Mkt Cap | $1.31B | Price | $18.15 |
| Volume | 1.10M | Change | +0.61% |
| P/E Ratio | -64.9 | Open | $18.25 |
| Revenue | $313.9M | Prev Close | $18.04 |
| Net Income | $-20.2M | 52W Range | $13.50 - $30.81 |
| Div Yield | N/A | Target | $23.92 |
| Overall | 42 | Value | 60 |
| Quality | 52 | Technical | 16 |
No chart data available
About STAAR Surgical Company
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Latest News
Staar Surgical appoints new board chair, restructures committees
Staar Surgical reshapes board under new investor agreement
Canaccord Genuity Sticks to Its Hold Rating for Staar Surgical (STAA)
Staar Surgical shareholders reject merger, company stays independent
Analysts Conflicted on These Healthcare Names: Alector (ALEC) and Staar Surgical (STAA)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | STAA | $18.15 | +0.6% | 1.10M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |